Rangadham Nagarakanti

1.9k total citations
35 papers, 1.3k citations indexed

About

Rangadham Nagarakanti is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Rangadham Nagarakanti has authored 35 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cardiology and Cardiovascular Medicine, 2 papers in Surgery and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Rangadham Nagarakanti's work include Atrial Fibrillation Management and Outcomes (24 papers), Cardiac Arrhythmias and Treatments (15 papers) and Cardiac pacing and defibrillation studies (6 papers). Rangadham Nagarakanti is often cited by papers focused on Atrial Fibrillation Management and Outcomes (24 papers), Cardiac Arrhythmias and Treatments (15 papers) and Cardiac pacing and defibrillation studies (6 papers). Rangadham Nagarakanti collaborates with scholars based in United States, Germany and Canada. Rangadham Nagarakanti's co-authors include Michael D. Ezekowitz, Paul Reilly, Lars Wallentin, Stuart J. Connolly, Salim Yusuf, Gerhard Nehmiz, Kambiz Parcham-Azad, Joachim Stangier, T.A. Simmers and Amit Parekh and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Rangadham Nagarakanti

32 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rangadham Nagarakanti United States 14 1.2k 480 108 92 87 35 1.3k
Gregory Y H Lip United Kingdom 13 863 0.7× 287 0.6× 141 1.3× 76 0.8× 89 1.0× 41 963
Matias Nordaby Germany 11 1.3k 1.1× 420 0.9× 75 0.7× 91 1.0× 228 2.6× 34 1.4k
Masahiro Esato Japan 21 1.5k 1.2× 249 0.5× 234 2.2× 136 1.5× 62 0.7× 65 1.5k
Hikari Tsuji Japan 18 1.1k 0.9× 237 0.5× 231 2.1× 120 1.3× 38 0.4× 43 1.1k
Mika Skeppholm Sweden 15 584 0.5× 270 0.6× 94 0.9× 56 0.6× 72 0.8× 23 728
Lars Hvilsted Rasmussen Denmark 5 617 0.5× 303 0.6× 70 0.6× 19 0.2× 75 0.9× 6 679
Olga Shestakovska Canada 18 1.0k 0.8× 348 0.7× 204 1.9× 137 1.5× 223 2.6× 27 1.1k
Mikhail Ruda United States 11 1.0k 0.8× 394 0.8× 51 0.5× 128 1.4× 229 2.6× 13 1.1k
Miklós Rohla Austria 15 419 0.3× 100 0.2× 67 0.6× 44 0.5× 125 1.4× 54 605
Willem J.M. Dewilde Netherlands 9 1.6k 1.3× 456 0.9× 65 0.6× 102 1.1× 488 5.6× 19 1.7k

Countries citing papers authored by Rangadham Nagarakanti

Since Specialization
Citations

This map shows the geographic impact of Rangadham Nagarakanti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rangadham Nagarakanti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rangadham Nagarakanti more than expected).

Fields of papers citing papers by Rangadham Nagarakanti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rangadham Nagarakanti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rangadham Nagarakanti. The network helps show where Rangadham Nagarakanti may publish in the future.

Co-authorship network of co-authors of Rangadham Nagarakanti

This figure shows the co-authorship network connecting the top 25 collaborators of Rangadham Nagarakanti. A scholar is included among the top collaborators of Rangadham Nagarakanti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rangadham Nagarakanti. Rangadham Nagarakanti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagarakanti, Rangadham, et al.. (2025). Cannabis Use and the Risk of Arrhythmias: Insights From a Large Retrospective Multicenter Analysis. Journal of Cardiovascular Electrophysiology. 36(12). 3261–3267.
2.
Nagarakanti, Rangadham, et al.. (2025). Heart’s Hidden Signal. JACC Case Reports. 30(19). 104007–104007.
3.
4.
Nagarakanti, Rangadham, Stuart J. Connolly, Mandy Fraessdorf, et al.. (2016). CLINICAL OUTCOMES OF ATRIAL FIBRILLATION PATIENTS RECEIVING DIGOXIN IN THE RE-LY ® TRIAL. Journal of the American College of Cardiology. 67(13). 802–802. 2 indexed citations
5.
Ezekowitz, Michael D., Helen Parise, Rangadham Nagarakanti, et al.. (2014). COMPARISON OF DABIGATRAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND VALVULAR HEART DISEASE: THE RE-LY® TRIAL. Journal of the American College of Cardiology. 63(12). A325–A325. 12 indexed citations
6.
Nagarakanti, Rangadham, Stuart J. Connolly, Martina Brueckmann, et al.. (2013). Benefits of Dabigatran versus Warfarin in Hypertensive Patients With Atrial Fibrillation : Results From The Re-ly Trial. Circulation. 128(22). 1 indexed citations
7.
Kaiser, Daniel W., Megan M. Streur, Rangadham Nagarakanti, S. Patrick Whalen, & Christopher R. Ellis. (2013). Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter. Journal of Interventional Cardiac Electrophysiology. 37(3). 241–247. 35 indexed citations
8.
Darius, Harald, Andreas Clemens, Jeff S. Healey, et al.. (2012). Abstract 15937: Comparison of Dabigatran versus Warfarin in Diabetic Patients with Atrial Fibrillation: Results from the RE-LY Trial. Circulation. 126. 4 indexed citations
9.
Nagarakanti, Rangadham, Satish R. Raj, & Jeffrey N. Rottman. (2012). Pacing Output Failure After Electrocautery During Pulse Generator Replacement. 3 indexed citations
10.
Shoemaker, M. Benjamin, Raafia Muhammad, Babar Parvez, et al.. (2012). Relation of Morbid Obesity and Female Gender to Risk of Procedural Complications in Patients Undergoing Atrial Fibrillation Ablation. The American Journal of Cardiology. 111(3). 368–373. 43 indexed citations
11.
Ezekowitz, Michael D., Rangadham Nagarakanti, Andrzej Lubiński, et al.. (2011). A randomized trial of budiodarone in paroxysmal atrial fibrillation. Journal of Interventional Cardiac Electrophysiology. 34(1). 1–9. 19 indexed citations
12.
Parekh, Amit, Stuart J. Connolly, Lars Wallentin, et al.. (2010). DABIGATRAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION - AN ANALYSIS OF PATIENTS UNDERGOING CARDIOVERSION. Journal of the American College of Cardiology. 55(10). A4.E40–A4.E40. 38 indexed citations
13.
Nagarakanti, Rangadham, et al.. (2010). Combination Antiplatelet Therapy for Secondary Stroke Prevention: Enhanced Efficacy or Double Trouble?. Journal of Vascular Surgery. 51(3). 782–782. 1 indexed citations
14.
Nagarakanti, Rangadham & D. Luke Glancy. (2010). Tall R Waves in Leads V1 to V3. Baylor University Medical Center Proceedings. 23(4). 432–433.
15.
Nagarakanti, Rangadham, et al.. (2009). Combination Antiplatelet Therapy for Secondary Stroke Prevention: Enhanced Efficacy or Double Trouble?. The American Journal of Cardiology. 103(8). 1107–1112. 36 indexed citations
16.
Saksena, Sanjeev & Rangadham Nagarakanti. (2008). The future of implantable defibrillator and cardiac resynchronization therapy trials. Journal of Interventional Cardiac Electrophysiology. 23(1). 29–39. 1 indexed citations
17.
Nagarakanti, Rangadham & Michael D. Ezekowitz. (2008). Diastolic dysfunction and atrial fibrillation. Journal of Interventional Cardiac Electrophysiology. 22(2). 111–118. 47 indexed citations
18.
Nagarakanti, Rangadham, Michael D. Ezekowitz, Kambiz Parcham-Azad, et al.. (2008). Abstract 4629: Long-Term Open Label Extension of the Prevention of Embolic and Thrombotic Events on Dabigatran in Atrial Fibrillation (PETRO- Ex study). Circulation. 118(suppl_18). 8 indexed citations
19.
Ezekowitz, Michael D., Paul Reilly, Gerhard Nehmiz, et al.. (2007). Dabigatran With or Without Concomitant Aspirin Compared With Warfarin Alone in Patients With Nonvalvular Atrial Fibrillation (PETRO Study). The American Journal of Cardiology. 100(9). 1419–1426. 332 indexed citations
20.
Nagarakanti, Rangadham, David J. Whellan, Sharon Rubin, & Paul Mather. (2007). Reversible Cardiomyopathies. Cardiology in Review. 15(4). 178–183. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gregory Y H Lip Breakdown of academic impact, for papers by Matias Nordaby Breakdown of academic impact, for papers by Masahiro Esato Breakdown of academic impact, for papers by Hikari Tsuji Breakdown of academic impact, for papers by Mika Skeppholm Breakdown of academic impact, for papers by Lars Hvilsted Rasmussen Breakdown of academic impact, for papers by Olga Shestakovska Breakdown of academic impact, for papers by Mikhail Ruda Breakdown of academic impact, for papers by Miklós Rohla Breakdown of academic impact, for papers by Willem J.M. Dewilde
Rankless by CCL
2026